Cutler Group LP 180 Life Sciences Corp. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$0.12 - $1.31 $21,360 - $233,180	-178,000 Reduced 71.66%	70,400 $1,000
Q2 2022 Aug 04, 2022	SELL	$0.81 - $2.53 $91,530 - $285,890	-113,000 Reduced 31.27%	248,400 $21,000
Q1 2022 Apr 14, 2022	SELL	$2.53 - $3.9 $48,322 - $74,490	-19,100 Reduced 5.02%	361,400 $92,000
Q4 2021 Jan 18, 2022	BUY	$3.27 - $6.38 $54,282 - $105,908	16,600 Added 4.56%	380,500 $302,000
Q3 2021 Oct 26, 2021	BUY	$5.11 - $10.81 $1.39 Million - $2.93 Million	271,500 Added 293.83%	363,900 $210,000
Q2 2021 Jul 19, 2021	BUY	$6.7 - $11.98 $124,620 - $222,828	18,600 Added 25.2%	92,400 $82,000
Q1 2021 Apr 26, 2021	BUY	$2.51 - $6.96 $185,237 - $513,648	73,800 New	73,800 $83,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $141M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.